Design, synthesis, photochemical properties and cytotoxic activities of water-Soluble caged l-Leucyl-l-leucine methyl esters that control apoptosis of immune cells
-
Add time:08/31/2019 Source:sciencedirect.com
l-Leucyl-l-leucine methyl esters (LeuLeuOMe) is a lysosomotropic agent that induces apoptosis of certain immune cells. Glucose-carrying 2-nitrobenzyl (2-NB) and 2-nitrophenethyl (2-NPE) caged LeuLeuOMe, 1a and b, were synthesized and their photochemical and immunological properties were studied. Caged glycine methyl esters (GlyOMe), 2a,b, were also prepared to examine the cytotoxic activity of the photolytic byproducts from 1a,b. All the caged compounds were soluble in PBS containing 1% DMSO more than 400 μM, and efficiently released the substrates upon irradiation at 350 nm. While both 1a and 1b were not toxic to HL60 cells, 1b released LeuLeuOMe more quickly and induced apoptosis of HL60 cells far more efficiently than 1a. Although GlyOMe was not cytotoxic, 2a and b were slightly toxic before and after irradiation almost to the similar extent. Therefore, the photolytic products from the caging groups appear to be not toxic to the cells, and the apoptosis inducing activity of 1a and b may be for the most part due to LeuLeuOMe.
We also recommend Trading Suppliers and Manufacturers of leucyl-leucine-methyl ester (cas 13022-42-9). Pls Click Website Link as below: cas 13022-42-9 suppliers
Prev:Research paperEpstein-Barr virus-induced transformation of human B lymphocytes: the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations
Next:Original ArticleEffects of the Immunosuppressive Dipeptide L-Leucyl-L-Leucine O-Methyl Ester on Epidermal Langerhans Cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical ResearchAntiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease09/05/2019
- Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk09/04/2019
- Treatment of donor cells with l-leucyl-l-leucine methyl ester prevents induction of graft-vs-host-like reaction in [lprlpr → +/+] chimera09/03/2019
- Regular ArticleSynthesis and Cytotoxic Studies of 5-O-(β–Glucopyranosyl)-2-nitrobenzyl Cagedl-Leucyl-l-Leucine Methyl Ester with Increased Solubility in PBS Containing 1% DMSO☆☆☆09/02/2019
- Original ArticleEffects of the Immunosuppressive Dipeptide L-Leucyl-L-Leucine O-Methyl Ester on Epidermal Langerhans Cells09/01/2019
- Research paperEpstein-Barr virus-induced transformation of human B lymphocytes: the effect of l-leucyl-l-leucine methyl ester on inhibitory T cell populations08/30/2019
- Regular ArticleSynthesis of Caged Compounds of L-Leucyl-L-Leucine Methyl Ester, an Apoptosis Inducer, and Their Cytotoxic Activity08/29/2019
- Regular ArticleCell-Type Specificity of l-Leucyl l-Leucine Methyl Ester08/28/2019


